- Home
- PB vs RGEN Comparison
PB vs RGEN Comparison
Compare PB & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PB
- RGEN
- Stock Information
- Founded
- PB 1983
- RGEN 1981
- Country
- PB United States
- RGEN United States
- Employees
- PB N/A
- RGEN N/A
- Industry
- PB Major Banks
- RGEN Medical/Dental Instruments
- Sector
- PB Finance
- RGEN Health Care
- Exchange
- PB Nasdaq
- RGEN Nasdaq
- Market Cap
- PB 6.6B
- RGEN 8.0B
- IPO Year
- PB 1998
- RGEN N/A
- Fundamental
- Price
- PB $69.69
- RGEN $118.07
- Analyst Decision
- PB Buy
- RGEN Buy
- Analyst Count
- PB 15
- RGEN 12
- Target Price
- PB $83.64
- RGEN $172.67
- AVG Volume (30 Days)
- PB 663.3K
- RGEN 791.0K
- Earning Date
- PB 07-23-2025
- RGEN 04-29-2025
- Dividend Yield
- PB 3.33%
- RGEN N/A
- EPS Growth
- PB 20.96
- RGEN N/A
- EPS
- PB 5.23
- RGEN N/A
- Revenue
- PB $1,212,807,000.00
- RGEN $650,429,000.00
- Revenue This Year
- PB $11.39
- RGEN $13.93
- Revenue Next Year
- PB $7.51
- RGEN $14.35
- P/E Ratio
- PB $13.31
- RGEN N/A
- Revenue Growth
- PB 11.62
- RGEN 4.88
- 52 Week Low
- PB $57.16
- RGEN $102.97
- 52 Week High
- PB $86.76
- RGEN $182.52
- Technical
- Relative Strength Index (RSI)
- PB 47.63
- RGEN 39.80
- Support Level
- PB $69.12
- RGEN $120.55
- Resistance Level
- PB $71.06
- RGEN $123.71
- Average True Range (ATR)
- PB 1.12
- RGEN 4.63
- MACD
- PB -0.30
- RGEN -0.58
- Stochastic Oscillator
- PB 16.47
- RGEN 7.59
About PB Prosperity Bancshares Inc.
Prosperity Bancshares Inc provides retail and commercial banking services to individuals and small to midsize businesses. It provides a wide array of financial products and services to businesses and consumers throughout Texas and Oklahoma. The group provides Personal, Business, Mortgage, and Banking Services.
About RGEN Repligen Corporation
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.